Literature DB >> 28427883

Born not breathing: A randomised trial comparing two self-inflating bag-masks during newborn resuscitation in Tanzania.

Monica Thallinger1, Hege Langli Ersdal2, Fortunata Francis3, Anita Yeconia4, Estomih Mduma5, Hussein Kidanto6, Jørgen Erland Linde7, Joar Eilevstjønn8, Nina Gunnes9, Ketil Størdal10.   

Abstract

AIMS: Effective ventilation is crucial to save non-breathing newborns. We compared standard equipment for newborn resuscitation to a new Upright bag, in an area with high neonatal mortality.
METHODS: Newborns requiring resuscitation at Haydom Lutheran Hospital, Tanzania, were ventilated with 230ml standard or 320ml Upright bag-mask by weekly non-blinded block randomisation. A Laerdal Newborn Resuscitation Monitor collected ventilation data through a flow sensor between mask and bag and heart rate with electrocardiography electrodes. Primary outcome was expiratory tidal volume per birth weight.
RESULTS: Of 6110 babies born, 136 randomised to standard bag-mask and 192 to Upright, both groups had similar birth weight, gestational age, Apgar scores, gender, and mode of delivery. Compared to standard bag-mask, Upright gave higher median expiratory tidal volume (8.6ml/kg (IQR: 3.5-13.8) vs. 10.0ml/kg (IQR: 4.3-16.8) difference ratio 1.29, 95%CI 1.05, 1.58, p=0.014)), increased mean airway and peak inspiratory pressures, and higher early expired CO2 (median at 20s 4.2% vs. 3.2%, p=0.0099). Clinical outcome 30min post-delivery was normal in 44% with standard versus 57% with Upright (p=0.016), but similar at 24h. CONCLUSION AND RELEVANCE: Upright provided higher expired tidal volume, MAP, PIP and early ECO2 than the standard bag. Clinical outcome differed at 30min, but not at 24h. Larger volume of Upright than standard bag can be an important factor. The results are relevant for low- and high-income settings as ventilatory and heart rate parameters during resuscitation of newborns are rarely reported. Trial registered at www.ClinicalTrials.gov, NCT01869582.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asphyxia Neonatorum; Bag-mask ventilation; Birth asphyxia; Developing countries; Infant mortality; Low-resource setting; Neonatal mortality; Neonatology; Newborn resuscitation; Positive Pressure Ventilation; Self-inflating bag; Stillbirth

Mesh:

Year:  2017        PMID: 28427883     DOI: 10.1016/j.resuscitation.2017.04.012

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  5 in total

1.  The first golden minute - Is it relevant?

Authors:  Tonia Branche; Marta Perez; Ola D Saugstad
Journal:  Resuscitation       Date:  2020-09-10       Impact factor: 5.262

2.  Predictors for expired CO2 in neonatal bag-mask ventilation at birth: observational study.

Authors:  Kari Holte; Hege Langli Ersdal; Joar Eilevstjønn; Monica Thallinger; Jørgen Linde; Claus Klingenberg; Rene Holst; Samwel Bayo; Hussein Kidanto; Ketil Stordal
Journal:  BMJ Paediatr Open       Date:  2019-09-26

3.  Frequent refresher training on newborn resuscitation and potential impact on perinatal outcome over time in a rural Tanzanian hospital: an observational study.

Authors:  Estomih Mduma; Jan Terje Kvaløy; Eldar Soreide; Erling Svensen; Paschal Mdoe; Jeffrey Perlman; Caroline Johnson; Hussein Lessio Kidanto; Hege Langli Ersdal
Journal:  BMJ Open       Date:  2019-09-27       Impact factor: 2.692

Review 4.  [Newborn resuscitation and support of transition of infants at birth].

Authors:  John Madar; Charles C Roehr; Sean Ainsworth; Hege Ersda; Colin Morley; Mario Rüdiger; Christiane Skåre; Tomasz Szczapa; Arjan Te Pas; Daniele Trevisanuto; Berndt Urlesberger; Dominic Wilkinson; Jonathan P Wyllie
Journal:  Notf Rett Med       Date:  2021-06-02       Impact factor: 0.892

5.  Increased perinatal survival and improved ventilation skills over a five-year period: An observational study.

Authors:  Ketil Størdal; Joar Eilevstjønn; Estomih Mduma; Kari Holte; Monica Thallinger; Jørgen Linde; Paschal Mdoe; Hussein Kidanto; Hege Langli Ersdal
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.